FR Bordeaux Rossignol R

                

---

---

FR Bordeaux Rossignol R

Oroboros O2k-Network

O2k-Network Lab	INSERM-EMI 9929Université Victor Segalen
Address	146, rue Léo Saignat, 33076
City	Bordeaux
State/Prov
Country	France
Weblink
Contact	Rossignol Rodrigue, Amoedo Nivea D
Team	Bellance Nadege, Gutierrez Cortes Nicolas, Mazat Jean-Pierre, Saharnaz Sarlak
Team previous	Jose Caroline
Status	2 Power-O2k 2003-
Oroboros Events	IOC137, MiP2015, MiP2014, MiP2013, Bioblast 2012, IOC72, IOC54, IOC39, IOC23, IOC13
Topics

O2k-Publications

	Published	Reference
Amoedo 2021 J Clin Invest	2021	Amoedo ND, Sarlak S, Obre E, Esteves P, Bégueret H, Kieffer Y, Rousseau B, Dupis A, Izotte J, Bellance N, Dard L, Redonnet-Vernhet I, Punzi G, Rodrigues MF, Dumon E, Mafhouf W, Guyonnet-Dupérat V, Gales L, Palama T, Bellvert F, Dugot-Senan N, Claverol S, Baste JM, Lacombe D, Rezvani HR, Pierri CL, Mechta-Grigoriou F, Thumerel M, Rossignol R (2021) Targeting the mitochondrial trifunctional protein restrains tumor growth in oxidative lung carcinomas. J Clin Invest 131:e133081.
Bastos Sant'Anna Silva 2021 Cancers (Basel)	2021	Bastos Sant'Anna Silva AC, Perez Valencia JA, Sciacovelli M, Lalou C, Sarlak S, Tronci L, Nikitopoulou E, Meszaros AT, Frezza C, Rossignol R, Gnaiger E, Klocker H (2021) Succinate anaplerosis has an onco-driving potential in prostate cancer cells. https://doi.org/10.3390/cancers13071727
Esteves 2019 Oncogene	2019	Esteves P, Dard L, Brillac A, Hubert C, Sarlak S, Rousseau B, Dumon E, Izotte J, Bonneu M, Lacombe D, Dupuy JW, Amoedo N, Rossignol R (2019) Nuclear control of lung cancer cells migration, invasion and bioenergetics by eukaryotic translation initiation factor 3F. Oncogene 39:617-36.
Jose 2018 Redox Biol	2018	Jose C, Hebert-Chatelain E, Dias Amoedo N, Roche E, Obre E, Lacombe D, Rezvani HR, Pourquier P, Nouette-Gaulain K, Rossignol R (2018) Redox mechanism of levobupivacaine cytostatic effect on human prostate cancer cells. Redox Biol 18:33-42.
Szelechowski 2018 Sci Rep	2018	Szelechowski M, Amoedo N, Obre E, Léger C, Allard L, Bonneu M, Claverol S, Lacombe D, Oliet S, Chevallier S, Le Masson G, Rossignol R (2018) Metabolic reprogramming in amyotrophic lateral sclerosis. Sci Rep 8:3953.
Rodrigues 2016 Biochem J	2015	Rodrigues MF, Obre E, Melo FH, Santos-Jr GC, Galina A, Jasiulionis MG, Rossignol R, Rumjanek FD, Amoedo ND (2016) Enhanced OXPHOS, glutaminolysis and beta-oxidation constitute the metastatic phenotype of melanoma cells. https://doi.org/10.1042/BJ20150645
Jose 2012 Thesis	2012	Jose C (2012) Rôle des mitochondries dans la tumorigénèse: implications pour le traitement du cancer. PhD Thesis 272.
Smolkova 2010 J Bioenerg Biomembr	2010	Smolková K, Bellance N, Scandurra F, Génot E, Gnaiger E, Plecitá-Hlavatá L, Ježek P, Rossignol R (2010) Mitochondrial bioenergetic adaptations of breast cancer cells to aglycemia and hypoxia. https://doi.org/10.1007/s10863-009-9267-x
Bellance 2009 Int J Biochem Cell Biol	2009	Bellance N, Benard G, Furt F, Begueret H, Smolková K, Passerieux E, Delage JP, Baste JM, Moreau P, Rossignol R (2009) Bioenergetics of lung tumors: Alteration of mitochondrial biogenesis and respiratory capacity. Int J Biochem Cell Biol 41:2566-77.

O2k-Abstracts

	Published	Reference
Amoedo 2015 Abstract MiP2015	2015	The energy requirement of metastatic cells.
Rodrigues 2014 Abstract MiP2014	2014	Bioenergetics’ traits of tongue cancer metastatic cells.

Bioblast alert

• Bioblast alert 2021 » Amoedo 2021 J Clin Invest